Brief: Alphamab Oncology Says HY Loss RMB103.1 Mln
28/08/2020 15:32
Aug 28 (Reuters) - Alphamab Oncology 9966.HK :
* HY LOSS RMB103.1 MILLION VERSUS LOSS OF RMB58.8 MILLION
Source text for Eikon: ID:nHKS7gvWyd
Further company coverage: 9966.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)